ProCE Banner Activity

BTK Inhibitor Therapy: A Guide for Patients and Their Caregivers on Avoiding and Managing Side Effects

PDF
Download this accessible resource developed for patients and caregivers on side effect care when receiving acalabrutinib, ibrutinib, or zanubrutinib.

Released: August 25, 2021

Expiration: August 24, 2022

No longer available for credit.

Share

Faculty

Anthony Perissinotti

Anthony Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
Clinical Team Leader
, Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan, Michigan Medicine
Roger Cancer Center
Ann Arbor, Michigan

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene Ltd

Faculty Disclosure

Primary Author

Anthony Perissinotti, PharmD, BCOP

Hematology Clinical Pharmacist Specialist
Clinical Team Leader
, Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan, Michigan Medicine
Roger Cancer Center
Ann Arbor, Michigan

Anthony Perissinotti, PharmD, BCOP, has disclosed that he has received consulting fees from Amgen, Pfizer, and Servier.